Trial · NCT01552915
Results by group15
Each measurement the trial posted, group by group, in the words and numbers it posted.
1 to 15 of 15
Download this page as JSON| Outcome | Group | Category | Value | Spread | Units |
|---|---|---|---|---|---|
| Change From Baseline in Attention-Deficit/Hyperactivity Disorder Rating Scale, Fourth Edition (ADHD-RS-IV) Total Score at Week 8 | Placebo | -13.4 | Standard Error 1.19 | units on a scale | |
| Change From Baseline in Attention-Deficit/Hyperactivity Disorder Rating Scale, Fourth Edition (ADHD-RS-IV) Total Score at Week 8 | SPD489 | -25.6 | Standard Error 0.82 | units on a scale | |
| Change From Baseline in Attention-Deficit/Hyperactivity Disorder Rating Scale, Fourth Edition (ADHD-RS-IV) Total Score at Week 8 | OROS-MPH | -23.5 | Standard Error 0.80 | units on a scale | |
| Percentage of Participants With Improvement on Clinical Global Impression - Global Improvement (CGI-I) at Week 8 - Last Observation Carried Forward (LOCF) | Placebo | 34.8 | percentage of participants | ||
| Percentage of Participants With Improvement on Clinical Global Impression - Global Improvement (CGI-I) at Week 8 - Last Observation Carried Forward (LOCF) | SPD489 | 83.1 | percentage of participants | ||
| Percentage of Participants With Improvement on Clinical Global Impression - Global Improvement (CGI-I) at Week 8 - Last Observation Carried Forward (LOCF) | OROS-MPH | 81.0 | percentage of participants | ||
| Change From Baseline in Systolic Blood Pressure at up to 8 Weeks - Last on Treatment Assessment | Placebo | -0.8 | Standard Deviation 8.97 | mmHg | |
| Change From Baseline in Systolic Blood Pressure at up to 8 Weeks - Last on Treatment Assessment | SPD489 | 2.4 | Standard Deviation 9.46 | mmHg | |
| Change From Baseline in Systolic Blood Pressure at up to 8 Weeks - Last on Treatment Assessment | OROS-MPH | 0.4 | Standard Deviation 9.90 | mmHg | |
| Change From Baseline in Diastolic Blood Pressure at up to 8 Weeks - Last on Treatment Assessment | Placebo | -1.2 | Standard Deviation 8.11 | mmHg | |
| Change From Baseline in Diastolic Blood Pressure at up to 8 Weeks - Last on Treatment Assessment | SPD489 | 2.8 | Standard Deviation 8.41 | mmHg | |
| Change From Baseline in Diastolic Blood Pressure at up to 8 Weeks - Last on Treatment Assessment | OROS-MPH | 2.2 | Standard Deviation 8.64 | mmHg | |
| Change From Baseline in Pulse Rate at up to 8 Weeks - Last on Treatment Assessment | Placebo | 0.3 | Standard Deviation 11.32 | bpm | |
| Change From Baseline in Pulse Rate at up to 8 Weeks - Last on Treatment Assessment | SPD489 | 4.7 | Standard Deviation 11.82 | bpm | |
| Change From Baseline in Pulse Rate at up to 8 Weeks - Last on Treatment Assessment | OROS-MPH | 6.0 | Standard Deviation 10.52 | bpm |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT01552915/results